Dr. Jerome Roth
Pharmacology And Toxicology
Professor
11 Cary Hall
Buffalo NY, 14214
Phone: (716) 829-3236
Email: jaroth@buffalo.edu

View map


OFFICE LOCATIONS

Office Location
11 Cary Hall
Buffalo NY, 14214

Phone: 829-3236
Email: jaroth@buffalo.edu
View map


DESCRIPTION OF INTERESTS

Dr. Jerome Roth‘s research interests over the past several years have focused on the mechanism of action of manganese in producing neuronal cell death. Manganese is an essential mineral that at high concentration acts as a neurotoxin which produces a Parkinson-like syndrome. Current studies are focused on characterizing the signal transduction pathways stimulated by manganese and to determine whether they also play a role in the toxic actions of this divalent cation. As part of this project we are also investigating the transport mechanisms by which manganese is taken up into cells. We have focussed our studies on the divalent metal transporter (DMT1)and its role in the transport of manganese and other divalent cations. We are currently studying the transcriptional and post-translational factors that regulate its expression in vivo. Preliminary studies have linked DMT1 expression to the protein parkin, mutations in which lead to early onset of Parkinson‘s disease.


SPECIALTIES

Apoptosis and cell death
Cell growth, development and Virology differentiation
Ion transport
Molecular and Cellular Biology
Neurobiology
Neurodegenerative disorders
Protein folding and structure
Proteins and metalloenzymes
Regulation of gene expression
Regulation of metabolism
Signal Transduction
Toxicology
Apoptosis and cell death
Cell growth, development and Virology differentiation
Ion transport
Molecular and Cellular Biology
Neurobiology
Neurodegenerative disorders
Protein folding and structure
Proteins and metalloenzymes
Regulation of gene expression
Regulation of metabolism
Signal Transduction
Toxicology


EDUCATION

1972 Postdoctoral Fellow, Biochemistry
Vanderbilt University
1971 PhD, Biochemistry
Cornell University
1967 M.N.S., Nutritional Science
Cornell University
1965 Bachelor of Science, State University of New York at New Paltz


PUBLICATIONS

Paradkar PN, Roth JA; Expression of the 1B isoforms of divalent metal transporter (DMT1) is regulated by interaction of NF-Y with a CCAAT-box element near the transcription start site.; J Cell Physiol; 2007 Apr; 211(1); 183-188
Garrick MD, Kuo HC, Vargas F, Singleton S, Zhao L, Smith JJ, Paradkar P, Roth JA, Garrick LM; Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion.; Biochem J; 2006 Sep; 398(3); 539-546
Paradkar PN, Roth JA; Nitric oxide transcriptionally down-regulates specific isoforms of divalent metal transporter (DMT1) via NF-kappaB.; J Neurochem; 2006 Mar; 96(6); 1768-1777
Garrick MD, Singleton ST, Vargas F, Kuo HC, Zhao L, Knöpfel M, Davidson T, Costa M, Paradkar P, Roth JA, Garrick LM; DMT1: which metals does it transport?; Biol Res; 2006 Jan; 39(1); 79-85
Roth JA; Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination.; Biol Res; 2006; 39; 45-57
Paradkar, P, Roth JA; Post-translational and Transcriptional Regulation of DMT1 during P19 Embryonic Carcinoma Cell Differentiation by Retinoic Acid; biochemical journal; 2006; 394; 173-183
Lis A, Paradkar PN, Singleton S, Kuo HC, Garrick MD, Roth JA; Hypoxia induces changes in expression of isoforms of the divalent metal transporter (DMT1) in rat pheochromocytoma (PC12) cells.; Biochem Pharmacol; 2005 Jun; 69(11); 1647-1655
Kuo HC, Smith JJ, Lis A, Zhao L, Gonsiorek EA, Zhou X, Higgins DM, Roth JA, Garrick MD, Garrick LM; Computer-identified nuclear localization signal in exon 1A of the transporter DMT1 is essentially ineffective in nuclear targeting.; J Neurosci Res; 2004 May; 76(4); 497-511
Lis A, Barone TA, Paradkar PN, Plunkett RJ, Roth JA; Expression and localization of different forms of DMT1 in normal and tumor astroglial cells.; Brain Res Mol Brain Res; 2004 Mar; 122(1); 62-70
Kuo, H.-C., Smith, J.J., Lis, A., Zhou, H., Gonsiorek, E.A., Zhou, X., Higgins, D.M., Roth, J.A., Garrick, M.D. and Garrick, L.M; A Computer-Identified Nuclear Localization Signal in Exon 1A of the Transporter DMT1 is Essentially Ineffective in Nuclear Targeting; J. Neurosci. Res.; 2004; 75;
ROTH JA; Expression and Localization of Different Forms of DMT1 in Normal and Tumor Astroglial Cells; Mol. Brain Research; 2004; 122; 62-70
Roth JA, Garrick MD; Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese.; Biochem Pharmacol; 2003 Jul; 66(1); 1-13
Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, Moore EG, Hainsworth LN, Umbreit JN, Conrad ME, Feng L, Lis A, Roth JA, Singleton S, Garrick LM; DMT1: a mammalian transporter for multiple metals.; Biometals; 2003 Mar; 16(1); 41-54
Michael Garrick, Dolan, KG, Horbinski, C, Ghio, A, Dennis Higgins, Porubcin, M, Moore, EG, Hainsworth, LN, Umbreit, JN, Conrad, ME, Feng, L, Lis, A, Jerome Roth; DMT1: A Mammalian Transporter for Multiple Metals. BioMetals; Biometals; 2003; 16; 41-54
Jerome Roth, Craig Horbinski, Dennis Higgins, Pam Lein, Michael Garrick; Mechanisms of manganese-induced rat pheochromocytoma (PC12) cell death and cell differentiation ; Neurotoxicology; 2002 Jul; 23(7); 147-157
Roth JA, Feng L, Dolan KG, Lis A, Garrick MD; Effect of the iron chelator desferrioxamine on manganese-induced toxicity of rat pheochromocytoma (PC12) cells.; J Neurosci Res; 2002 Apr; 68(1); 76-83
Jerome Roth Craig Horbinski Dennis Higgins Pam Lein Michael Garrick ; Manganese-induced rat pheochromocytoma (PC12) cell death and cell differentiation; Neurotoxicology; 2002 Jan; 23; 147-157
Roth JA, Horbinski C, Higgins D, Lein P, Garrick MD; Mechanisms of manganese-induced rat pheochromocytoma (PC12) cell death and cell differentiation.; Neurotoxicology; 2002; 23; 147-157
Roth JA, Rosenblatt T, Lis A, Bucelli R; Melatonin-induced suppression of PC12 cell growth is mediated by its Gi coupled transmembrane receptors.; Brain Res; 2001 Nov; 919(1); 139-146
Lein P, Gallagher PJ, Amodeo J, Howie H, Roth JA; Manganese induces neurite outgrowth in PC12 cells via upregulation of alpha(v) integrins.; Brain Res; 2000 Dec; 885(2); 220-230
Roth JA, Feng L, Walowitz J, Browne RW; Manganese-induced rat pheochromocytoma (PC12) cell death is independent of caspase activation.; J Neurosci Res; 2000 Jul; 61(2); 162-171
Jerome Roth, Horbinski C, Feng L, Dolan KG, Dennis Higgins, Michael Garrick; Differential localization of divalent metal transporter 1 with and without iron response element in rat PC12 and sympathetic neuronal cells.; J Neurosci; 2000; 20; 7595-7601
Walowitz JL, Roth JA; Activation of ERK1 and ERK2 is required for manganese-induced neurite outgrowth in rat pheochromocytoma (PC12) cells.; J Neurosci Res; 1999 Sep; 57(6); 847-854
Roth JA, Kim BG, Lin WL, Cho MI; Melatonin promotes osteoblast differentiation and bone formation; J Biol Chem; 1999 Jul; 274(31); 22041-22047
Larsen KE, Pacheco M, Roth J, Aletta JM; Increased MAP1B expression without increased phosphorylation in manganese-treated PC12Mn cells.; Exp Cell Res; 1998 Nov; 245(1); 105-115
Roth J, Rabin R, Agnello, K; Melatonin suppression of PC12 cell growth and death; Brain Research; 1997; 768; 63-70
Lin WH, Marcucci K, Roth JA; Effect of manganese on tyrosylprotein sulfotransferase activity in PC12 cells.; Biochem Pharmacol; 1994 Apr; 47(9); 1575-1580
Lin WH, Higgins D, Pacheco M, Aletta J, Perini S, Marcucci KA, Roth JA; Manganese induces spreading and process outgrowth in rat pheochromocytoma (PC12) cells.; J Neurosci Res; 1993; 34; 546-561
Spaulding SW, Smith TJ, Hinkle PM, Davis FB, Kung MP, Roth JA; Studies on the biological activity of triiodothyronine sulfate.; J Clin Endocrinol Metab; 1992 May; 74(5); 1062-1067
Lin WH, Marcucci KA, Rabin RA, Roth JA; 2-Chloroadenosine decreases tyrosylprotein sulfotransferase activity in the Golgi apparatus in PC12 cells. Evidence for a novel receptor.; J Biol Chem; 1991 Aug; 266(22); 14457-14463
Roth JA, Marcucci K, Lin WH, Napoli JL, Wagner JA, Rabin R; Increase in beta-1,4-galactosyltransferase activity during PC12 cell differentiation induced by forskolin and 2-chloroadenosine.; J Neurochem; 1991 Aug; 57(2); 708-713
Zou JY, Petney R, Roth JA; Immunohistochemical detection of phenol sulfotransferase-containing neurons in human brain.; J Neurochem; 1990 Oct; 55(4); 1154-1158
Roth JA, Grossman MH, Adolf M; Variation in hepatic membrane-bound catechol-O-methyltransferase activity in Fischer and Wistar-Furth strains of rat.; Biochem Pharmacol; 1990 Sep; 40(5); 1151-1153
Lin WH, Roth JA; Characterization of a tyrosylprotein sulfotransferase in human liver.; Biochem Pharmacol; 1990 Aug; 40(3); 629-635
Falany CN, Vazquez ME, Heroux JA, Roth JA; Purification and characterization of human liver phenol-sulfating phenol sulfotransferase.; Arch Biochem Biophys; 1990 May; 278(2); 312-318
Rens-Domiano S, Hortin GL, Roth JA; Sulfation of tert-butoxycarbonylcholecystokinin and other peptides by rat liver tyrosylprotein sulfotransferase.; Mol Pharmacol; 1989 Oct; 36(4); 647-653
Rens-Domiano S, Roth JA; Characterization and post-natal development of rat cerebellum tyrosylprotein sulfotransferase.; Biochem Pharmacol; 1989 Sep; 38(17); 2930-2932
Heroux JA, Falany CN, Roth JA; Immunological characterization of human phenol sulfotransferase.; Mol Pharmacol; 1989 Jul; 36(1); 29-33
Kung MP, Nickerson PA, Sansone FM, Olson JR, Kostyniak PJ, Adolf MA, Roth JA; Effect of chronic exposure to hexachlorophene on rat brain cell specific marker enzymes.; Neurotoxicology; 1989 Jun; 10(2); 201-210
Kung MP, Kostyniak PJ, Olson JR, Sansone FM, Nickerson PA, Malone MA, Ziembiec N, Roth JA; Cell specific enzyme markers as indicators of neurotoxicity: effects of acute exposure to methylmercury.; Neurotoxicology; 1989 Jan; 10(1); 41-52
Kung MP, Kostyniak PJ, Olson JR, Sansone FM, Nickerson PA, Malone MA, Ziembiec N, Roth JA; Cell specific enzyme markers as indicators of neurotoxicity: effects of acuteexposure to methylmercury.; Neurotoxicology; 1989; 10(1); 41-52
Rens-Domiano S, Roth JA; Characterization of tyrosylprotein sulfotransferase from rat liver and other tissues.; J Biol Chem; 1989 Jan; 264(2); 899-905
Kung MP, Nickerson PA, Sansone FM, Olson JR, Kostyniak PJ, Adolf MA, Lein PJ, Roth JA; Effect of short-term exposure to hexachlorophene on rat brain cell specific marker enzymes.; Fundam Appl Toxicol; 1988 Oct; 11(3); 519-527
Heroux JA, Roth JA; Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets.; Mol Pharmacol; 1988 Aug; 34(2); 194-199
Kung MP, Spaulding SW, Roth JA; Desulfation of 3,5,3'-triiodothyronine sulfate by microsomes from human and rat tissues.; Endocrinology; 1988 Apr; 122(4); 1195-1200
Kung MP, Roth JA; Cellular localization of soluble and membrane-bound forms of arylsulfatase in rat brain.; Brain Res; 1987 Sep; 419(1-2); 141-146
Francis A, Whittemore R, Jeffery DR, Pearce LB, Roth JA; Catecholamine-metabolizing enzyme activity in the nigrostriatal system.; Biochem Pharmacol; 1987 Jul; 36(13); 2229-2231
Rens-Domiano SS, Roth JA; Inhibition of M and P phenol sulfotransferase by analogues of 3'-phosphoadenosine-5'-phosphosulfate.; J Neurochem; 1987 May; 48(5); 1411-1415
Jeffery DR, Roth JA; Kinetic reaction mechanism for magnesium binding to membrane-bound and soluble catechol O-methyltransferase.; Biochemistry; 1987 May; 26(10); 2955-2958
Kung MP, Kostyniak P, Olson J, Malone M, Roth JA; Studies of the in vitro effect of methylmercury chloride on rat brain neurotransmitter enzymes.; J Appl Toxicol; 1987 Apr; 7(2); 119-121
Roth JA, Morphy M, Szymanski H; Formation of adenosine-5'-phosphosulfate from 3'-phosphoadenosine-5'-phosphosulfate in human platelets.; Biochem Pharmacol; 1986 Oct; 35(20); 3646-3649
Whittemore RM, Pearce LB, Roth JA; Purification and kinetic characterization of a phenol-sulfating form of phenol sulfotransferase from human brain.; Arch Biochem Biophys; 1986 Sep; 249(2); 464-471
Whittemore RM, Roth JA; Effect of phosphatase inhibition of in vitro dopamine sulfation and 3'-phosphoadenosine-5'-phosphosulfate catabolism in human brain.; Biochem Pharmacol; 1985 Nov; 34(21); 3853-3856
Whittemore RM, Roth JA; A modified Ecteola cellulose assay for M and P phenol sulfotransferase.; Biochem Pharmacol; 1985 May; 34(10); 1647-1652
Francis A, Pearce LB, Roth JA; Cellular localization of MAO A and B in brain: evidence from kainic acid lesions in striatum.; Brain Res; 1985 May; 334(1); 59-64
Whittemore RM, Pearce LB, Roth JA; Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain.; Biochemistry; 1985 May; 24(10); 2477-2482
Pearce LB, Roth JA; Human brain monoamine oxidase type B: mechanism of deamination as probed by steady-state methods.; Biochemistry; 1985 Apr; 24(8); 1821-1826
Jeffery DR, Roth JA; Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase.; J Neurochem; 1985 Mar; 44(3); 881-885
Pearce LB, Roth JA; Monoamine oxidase: separation of the type A and B activities.; Biochem Pharmacol; 1984 Jun; 33(11); 1809-1811
Rivett AJ, Francis A, Whittemore R, Roth JA; Sulfate conjugation of dopamine in rat brain: regional distribution of activity and evidence for neuronal localization.; J Neurochem; 1984 May; 42(5); 1444-1449
Jeffery DR, Roth JA; Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex.; J Neurochem; 1984 Mar; 42(3); 826-832
Pearce LB, Roth JA; Human brain monoamine oxidase: solubilization and kinetics of inhibition by octylglucoside.; Arch Biochem Biophys; 1983 Jul; 224(2); 464-472
Rivett AJ, Francis A, Roth JA; Localization of membrane-bound catechol-O-methyltransferase.; J Neurochem; 1983 May; 40(5); 1494-1496
Francis A, Rivett AJ, Roth JA; Activity of neuron-specific enolase in normal and lesioned rat brain.; Brain Res; 1983 Mar; 263(1); 89-95
Rivett AJ, Francis A, Roth JA; Distinct cellular localization of membrane-bound and soluble forms of catechol-O-methyltransferase in brain.; J Neurochem; 1983 Jan; 40(1); 215-219
Rivett AJ, Eddy BJ, Roth JA; Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain.; J Neurochem; 1982 Oct; 39(4); 1009-1016
Roth JA, Rivett AJ; Does sulfate conjugation contribute to the metabolic inactivation of catecholamines in humans?; Biochem Pharmacol; 1982 Oct; 31(19); 3017-3021
Rivett AJ, Roth JA; Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase.; Biochemistry; 1982 Apr; 21(8); 1740-1742
Roth JA, Eddy BJ, Pearce LB, Mulder KM; Phenylhydrazine: selective inhibition of human brain type B monoamine oxidase.; Biochem Pharmacol; 1981 May; 30(9); 945-950
Roth JA, Eddy BJ; Kinetic properties of membrane-bound and Triton X-100-solubilized human brain monoamine oxidase.; Arch Biochem Biophys; 1980 Nov; 205(1); 260-266
Young JG, Cohen DJ, Waldo MC, Feiz R, Roth JA; Platelet monoamine oxidase activity in children and adolescents with psychiatric disorders.; Schizophr Bull; 1980 Jan; 6(2); 324-333
Snyder AM, Hull EM, Roth JA; The effect of maternal progesterone injections on fetal development of brain monoamine oxidase of rats.; Brain Res; 1979 Jul; 170(1); 194-197
Roth JA; Benzylhydrazine--a selective inhibitor of human and rat brain monoamine oxidase.; Biochem Pharmacol; 1979 Mar; 28(6); 729-732
Roth JA, Whittemore RM, Shakarjian MP, Eddy BJ; Inhibition of human brain type A and B monoamine oxidase by chloropromazine and metabolites.; Commun Psychopharmacol; 1979 Jan; 3(4); 235-243
Franz JR, Hull EM, Snyder AM, Roth JA; The effect of maternal progesterone on brain monoamine oxidase activity of neonatal rats.; Brain Res; 1978 Dec; 158(2); 397-406
Young JG, Cohen DJ, Roth JA; Association between platelet monoamine oxidase activity and hematocrit in childhood autism.; Life Sci; 1978 Aug; 23(8); 797-806
Roth JA, Feor K; Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.; Biochem Pharmacol; 1978 Jan; 27(11); 1606-1608
Roth JA; Inhibition of human brain type B monoamine oxidase by tricyclic psychoactive drugs.; Mol Pharmacol; 1978 Jan; 14(1); 164-171
Roth JA, Venter JC; Predominance of the B form of monoamine oxidase in cultured vascular intimal endothelial cells.; Biochem Pharmacol; 1978 Jan; 27(19); 2371-2373
Cohen DJ, Young JG, Roth JA; Platelet monoamine oxidase in early childhood autism.; Arch Gen Psychiatry; 1977 May; 34(5); 534-537
Roth JA, Breakefield XO, Castiglione CM; Monoamine oxidase and catechol-O-methyltransferase activities in cultured human skin fibroblasts.; Life Sci; 1976 Dec; 19(11); 1705-1710
Roth JA; Multiple forms of monoamine oxidase and their interaction with tricyclic psychomimetic drugs.; Gen Pharmacol; 1976 Dec; 7(6); 381-386
Roth JA; Evidence for a single catalytic binding site on human brain type B monoamine oxidase.; J Neurochem; 1976 Nov; 27(5); 1107-1112
Roth JA, Young JG, Cohen DJ; Platelet monoamine oxidase activity in children and adolescents.; Life Sci; 1976 May; 18(9); 919-924
Roth JA, Gillis CN; Multiple forms of amine oxidase in perfused rabbit lung.; J Pharmacol Exp Ther; 1975 Sep; 194(3); 537-544
Roth JA; Inhibition of rabbit monoamine oxidase by doxepin and related drugs.; Life Sci; 1975 Apr; 16(8); 1309-1319
Gillis CN, Roth JA, Baker KR; Evidence for different forms of monoamine oxidase in perfused rabbit lung.; Chest; 1975 Feb; 67(2 Sup); 26-28
Roth JA, Gillis CN; Inhibition of rabbit mitochondrial monoamine oxidase by iprindole.; Biochem Pharmacol; 1975 Jan; 24(1); 151-152
Roth JA, Gillis CN; Some structural requirements for inhibition of type A and B forms of rabbit monoamine oxidase by tricyclic psychoactive drugs.; Mol Pharmacol; 1975 Jan; 11(1); 28-35
Roth JA, Gillis CN; Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.; Biochem Pharmacol; 1974 Sep; 23(18); 2537-2545
Roth JA, Gillis CN; Inhibition of lung, liver and brain monoamine oxidase by imipramine and desipramine.; Biochem Pharmacol; 1974 Mar; 23(6); 1138-1140
Norman BJ, Roth JA, Neal RA; Effect of temperature on the mixed function oxidase-catalyzed metabolism of O,O-diethyl p-nitrophenyl phosphorothionate (parathion).; Toxicol Appl Pharmacol; 1973 Oct; 26(2); 203-208
Roth JA;
Garrick MD, Singleton ST, Vargas F, Kuo HC, Zhao L, Knöpfel M, Davidson T, Costa M, Paradkar P, Roth JA, Garrick LM; DMT1: which metals does it transport?; Biol Res; 39(1); 79-85
Kung MP, Nickerson P, Sansone FM, Olson J, Kostyniak P, Adolf M, Roth J; Effect of chronic exposure to hexachlorophene on rat brain cell specific marker enzymes.;
Kung MP, Nickerson P, Sansone FM, Olson J, Kostyniak P, Adolf M, Lein PJ, Roth J; Effect of short-term exposure to hexachlorophene on rat brain cell specific marker enzymes.;


GRANTS

March 2002 to March 2005
Divalent Metal Transporter: Role in Manganese Toxicity
NIH/NIEHS
Jerome Roth, Michael Garrick, Dennis Higgins
$808,500



 
Dr. Jerome Roth
Dr. Jerome Roth